Search

Displaying results 6791 - 6800 of 10000 in total
  1. Drug

    ASF-1075

    go.drugbank.com/drugs/DB05727
    Experimental

  2. Drug

    EMD-1201081

    go.drugbank.com/drugs/DB06181
    Investigational

  3. Drug

    Repifermin

    go.drugbank.com/drugs/DB06434
    Experimental

  4. Drug

    Edifoligide

    go.drugbank.com/drugs/DB06556
    Investigational

  5. Drug

    PRX-08066

    go.drugbank.com/drugs/DB05607
    Investigational

  6. Drug

    Regrelor

    go.drugbank.com/drugs/DB05553
    Investigational

  7. Drug

    RO7296682

    go.drugbank.com/drugs/DB17531
    Investigational

    RO7296682 is under investigation in clinical trial NCT04642365 (A Study to Evaluate the Safety and Tolerability of RO7296682 in Combination With Atezolizumab in Participants With Advanced Solid Tumors. … RO7296682 is a monoclonal antibody against CD25 (IL-2R alpha) expressed on tumour-infiltrating regulatory T (T<sub>reg</sub>) cells.

  8. Drug

    Luveltamab tazevibulin

    go.drugbank.com/drugs/DB17563
    Investigational

    [A257414] It is under investigation in clinical trial NCT05200364 (A Study of STRO-002, an Anti-folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer … Luveltamab tazevibulin, formerly known as STRO-002, is novel homogeneous folate receptor alpha (FolRα) targeting antibody-drug conjugate.

  9. Drug

    Tanomastat

    go.drugbank.com/drugs/DB06276
    Experimental

  10. Drug

    Pramiconazole

    go.drugbank.com/drugs/DB06295
    Experimental